Global Immunology Market Growth (Status and Outlook) 2023-2029

Global Immunology Market Growth (Status and Outlook) 2023-2029

The immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the abnormal cells including cancerous cells. The inherent self-defense system comprises cells, which help the body in the identification of foreign molecules. Different pathways regulate various immune cells for distinguishing body's healthy cells and disease-causing foreign agents such as a virus: parasite, bacteria, fungi, and cancerous cells. To maintain the body's defense against the continuously evolving organisms, which try to attack the body in numerous ways, continuous modification of all the components of the immune system is essential. Sometimes, the continuously modifying immune system reacts against the body's cells, considering them as foreign agents, which results in the destruction of healthy tissues and becomes the cause of autoimmune diseases and cancers. The inherent state of unresponsiveness may also be observed due to the weakened body defense owing to the genetic reasons that result in immunodeficiency disease.

LPI (LP Information)' newest research report, the “Immunology Industry Forecast” looks at past sales and reviews total world Immunology sales in 2022, providing a comprehensive analysis by region and market sector of projected Immunology sales for 2023 through 2029. With Immunology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunology industry.

This Insight Report provides a comprehensive analysis of the global Immunology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immunology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immunology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunology.

The global Immunology market size is projected to grow from US$ 62840 million in 2022 to US$ 99220 million in 2029; it is expected to grow at a CAGR of 6.7% from 2023 to 2029.

One of the major drivers for this market is growing cases of infectious diseases. Infectious diseases such as hepatitis and acquired immunodeficiency syndrome (AIDS) are rampant globally. When the body's immune system is unable to resist the invading pathogens or microbes, it gives way to infections. Infectious diseases such as hepatitis and AIDS can be treated by immunomodulators. Agents that help in boosting the immunity of the human body help in resisting pathogens. According to the CDC, there are more than a million AIDS-affected people in the US. With the rising incidences of infectious diseases, the demand for immunology products will increase in the following years.

This report presents a comprehensive overview, market shares, and growth opportunities of Immunology market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Immuno Boosters
Immunosuppressants

Segmentation by application
Autoimmune Diseases
Oncology
Organ Transplantation
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Bionor Pharma
Celgene
Cellectar Biosciences
eFFECTOR Therapeutics

Please note: The report will take approximately 2 business days to prepare and deliver.